Results 31 to 40 of about 1,394 (181)

International Consensus Histopathological Criteria for Subtyping Idiopathic Multicentric Castleman Disease Based on Machine Learning Analysis. [PDF]

open access: yesAm J Hematol
ABSTRACT Idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder classified into three recognized clinical subtypes—idiopathic plasmacytic lymphadenopathy (IPL), TAFRO, and NOS. Although clinical criteria are available for subtyping, diagnostically challenging cases with overlapping histopathological features highlight ...
Nishimura MF   +14 more
europepmc   +2 more sources

Idiopathic Multicentric Castleman Disease With Severe Eosinophilia and Diffuse Centrilobular Nodule-A Rare Case Report. [PDF]

open access: yesCase Rep Hematol
Rationale Idiopathic multicentric Castleman disease (iMCD), also known as angiofollicular lymph node hyperplasia, is a rare inflammatory lymphoproliferative disease with diverse clinical presentations. We report a rare case of iMCD accompanied by severe eosinophilia and diffuse centrilobular pulmonary nodules, which have rarely been previously ...
Li X   +6 more
europepmc   +2 more sources

Dynamics of Serum Cytokines and Chemokines in Patients With Idiopathic Multicentric Castleman Disease: From a Phase Ib Investigator-Initiated Trial of Filgotinib. [PDF]

open access: diamondCureus
Fukui S   +13 more
europepmc   +2 more sources

Idiopathic multicentric Castleman’s disease [PDF]

open access: yesTerapevticheskii arkhiv, 2020
Idiopathic multicentric Castlemans disease is a rare lymphoproliferative disorder that has many similar laboratory, radiological, clinical and pathological manifestations with various conditions, including IgG4-related disease. Increased activity of cytokines, especially interleukin-6, leads to systemic inflammatory symptoms with the development of ...
V. I. Vasilyev   +5 more
openaire   +3 more sources

Clinical Characteristics and Prognosis of Pediatric Idiopathic Multicentric Castleman Disease [PDF]

open access: bronzeAmerican Journal of Hematology
Yuhan Gao   +8 more
openalex   +3 more sources

Candidate biomarkers for idiopathic multicentric Castleman disease

open access: yesJournal of Clinical and Experimental Hematopathology, 2022
The clinical manifestations of idiopathic multicentric Castleman disease (iMCD) are thought to be caused by an excess of inflammatory cytokines; however, the mechanism is yet to be known. In addition to IL-6, inflammatory cytokines, such as IL-1β and TNF-α, are noted to be elevated in iMCD, which are common in autoinflammatory diseases.
Sumiyoshi, Remi   +2 more
openaire   +2 more sources

Curative Gastrectomy for Advanced Gastric Cancer in a Patient with Idiopathic Multicentric Castleman Disease: A Rare Case Report [PDF]

open access: goldSurg Case Rep
Kawabata R   +12 more
europepmc   +3 more sources

Multicentric Castleman’s Disease, Associated with Idiopathic Thrombocytopenic Purpura [PDF]

open access: yesCase Reports in Hematology, 2013
The most common cause of a neck mass in young adults is hyperplastic lymphadenopathy consequent to infection and inflammation. Castleman’s disease (CD), an unusual benign lymphoproliferative disorder, infrequently causes neck masses. It occurs in unicentric (UCD) and multicentric (MCD) forms and is associated with human immunodeficiency virus (HIV ...
Ruchi Sood, Harris C. Taylor, Hamed Daw
openaire   +4 more sources

Pediatric multicentric Castleman disease; a case report [PDF]

open access: yesJournal of Clinical and Investigative Surgery, 2022
Castleman disease (CD) is a rare B-cell lymphoproliferative disorder of unknown etiology characterized by benign lymphoid follicular hyperplasia and capillary proliferation.
Gabriela Alfier   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy